About ReAlta Life Sciences
ReAlta Life Sciences is a company based in Norfolk (United States) founded in 2018. It operates as a HealthTech. ReAlta Life Sciences has raised $81.5 million across 4 funding rounds from investors including Marathon Pharma. The company has 19 employees as of December 31, 2021. ReAlta Life Sciences offers products and services including RLS-0071 (pegtarazimod) and EPICC Platform. ReAlta Life Sciences operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Norfolk, United States
- Employees 19 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Realta Life Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$81.5 M (USD)
in 4 rounds
-
Latest Funding Round
$25 M (USD), Series B
Dec 18, 2024
- Investors
-
Employee Count
19
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReAlta Life Sciences
ReAlta Life Sciences offers a comprehensive portfolio of products and services, including RLS-0071 (pegtarazimod) and EPICC Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug developed for rare inflammatory disease treatment purposes.
Platform used for dual-targeting inflammatory response moderation.
Unlock access to complete
Unlock access to complete
Funding Insights of ReAlta Life Sciences
ReAlta Life Sciences has successfully raised a total of $81.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $25.0M
-
First Round
First Round
(21 Apr 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series B - ReAlta Life Sciences | Valuation |
investors |
|
| Sep, 2023 | Amount | Series B - ReAlta Life Sciences | Valuation |
investors |
|
| Apr, 2021 | Amount | Series A - ReAlta Life Sciences | Valuation | Marathon Pharma |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReAlta Life Sciences
ReAlta Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Marathon Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
New treatments for rare neurological and movement disorders are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReAlta Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ReAlta Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Realta Life Sciences Comparisons
Competitors of ReAlta Life Sciences
ReAlta Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Realta Life Sciences
Frequently Asked Questions about ReAlta Life Sciences
When was ReAlta Life Sciences founded?
ReAlta Life Sciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is ReAlta Life Sciences located?
ReAlta Life Sciences is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Who is the current CEO of ReAlta Life Sciences?
Ulrich Thienel is the current CEO of ReAlta Life Sciences.
Is ReAlta Life Sciences a funded company?
ReAlta Life Sciences is a funded company, having raised a total of $81.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $20M, raised on Apr 21, 2020.
How many employees does ReAlta Life Sciences have?
As of Dec 31, 2021, the latest employee count at ReAlta Life Sciences is 19.
What does ReAlta Life Sciences do?
ReAlta Life Sciences, a clinical-stage company, is dedicated to addressing rare diseases through innovative drug development. The company has created a novel class of drugs utilizing the EPICC platform, which offers dual-targeting therapeutic capabilities to rebalance complement and inflammatory processes. Research and development initiatives are centered on acute inflammatory and rare diseases such as Hypoxic Ischemic Encephalopathy, Acute Exacerbations of COPD, Graft-versus-Host Disease, and Platelet Refractoriness. Solutions are developed to modify disease progression by moderating robust components of humoral and cellular inflammatory responses across various therapeutic areas.
Who are the top competitors of ReAlta Life Sciences?
ReAlta Life Sciences's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does ReAlta Life Sciences offer?
ReAlta Life Sciences offers RLS-0071 (pegtarazimod) and EPICC Platform.
Who are ReAlta Life Sciences's investors?
ReAlta Life Sciences has 1 investor. Key investors include Marathon Pharma.